{"entity":{"type":"insider","cik":"0001578908","url":"/insider/0001578908","json_url":"/insider/0001578908.json","name":"HEINEN ERNST","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":9,"first":"2014-05-05","last":"2018-11-09","span_basis":"filed_date"},"name_variants":[{"name":"HEINEN ERNST","source":"filing","n_filings":9,"first_seen":"2014-05-05","last_seen":"2018-11-09"}],"transactions":[{"id":6662767,"accession":"0001209191-18-058010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-058010","line_url":"/filing/0001209191-18-058010#line-1","is_derivative":false,"issuer_cik":"0001509190","issuer_name":"ARATANA THERAPEUTICS, INC.","issuer_ticker":"PETX","issuer_name_source":null,"issuer_url":"/issuer/0001509190","owner_cik":"0001578908","owner_name":"HEINEN ERNST","owner_display_name":"HEINEN ERNST","owner_url":"/insider/0001578908","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19308.0,"shares_display":"19,308","price_per_share":6.95,"price_display":"6.95","price_state":"stated","total_value":134190.6,"total_display":"134,190.60","total_whole":"134,191","shares_owned_after":135694.0,"shares_owned_after_display":"135,694","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-07","filed_date":"2018-11-09","scope":"insider"},{"id":6869575,"accession":"0001209191-18-057449","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-057449","line_url":"/filing/0001209191-18-057449#line-1","is_derivative":false,"issuer_cik":"0001509190","issuer_name":"ARATANA THERAPEUTICS, INC.","issuer_ticker":"PETX","issuer_name_source":null,"issuer_url":"/issuer/0001509190","owner_cik":"0001578908","owner_name":"HEINEN ERNST","owner_display_name":"HEINEN ERNST","owner_url":"/insider/0001578908","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":692.0,"shares_display":"692","price_per_share":6.95,"price_display":"6.95","price_state":"stated","total_value":4809.4,"total_display":"4,809.40","total_whole":"4,809","shares_owned_after":155002.0,"shares_owned_after_display":"155,002","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-02","filed_date":"2018-11-06","scope":"insider"},{"id":6292568,"accession":"0001209191-18-046658","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-046658","line_url":"/filing/0001209191-18-046658#line-2","is_derivative":false,"issuer_cik":"0001509190","issuer_name":"ARATANA THERAPEUTICS, INC.","issuer_ticker":"PETX","issuer_name_source":null,"issuer_url":"/issuer/0001509190","owner_cik":"0001578908","owner_name":"HEINEN ERNST","owner_display_name":"HEINEN ERNST","owner_url":"/insider/0001578908","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1712.0,"shares_display":"1,712","price_per_share":5.15,"price_display":"5.15","price_state":"stated","total_value":8816.8,"total_display":"8,816.80","total_whole":"8,817","shares_owned_after":155694.0,"shares_owned_after_display":"155,694","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-14","filed_date":"2018-08-14","scope":"insider"},{"id":6292563,"accession":"0001209191-18-046658","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-046658","line_url":"/filing/0001209191-18-046658#line-1","is_derivative":false,"issuer_cik":"0001509190","issuer_name":"ARATANA THERAPEUTICS, INC.","issuer_ticker":"PETX","issuer_name_source":null,"issuer_url":"/issuer/0001509190","owner_cik":"0001578908","owner_name":"HEINEN ERNST","owner_display_name":"HEINEN ERNST","owner_url":"/insider/0001578908","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8660.0,"shares_display":"8,660","price_per_share":5.15,"price_display":"5.15","price_state":"stated","total_value":44599.0,"total_display":"44,599.00","total_whole":"44,599","shares_owned_after":157406.0,"shares_owned_after_display":"157,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-13","filed_date":"2018-08-14","scope":"insider"},{"id":6586180,"accession":"0001209191-18-046294","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-046294","line_url":"/filing/0001209191-18-046294#line-2","is_derivative":false,"issuer_cik":"0001509190","issuer_name":"ARATANA THERAPEUTICS, INC.","issuer_ticker":"PETX","issuer_name_source":null,"issuer_url":"/issuer/0001509190","owner_cik":"0001578908","owner_name":"HEINEN ERNST","owner_display_name":"HEINEN ERNST","owner_url":"/insider/0001578908","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1954.0,"shares_display":"1,954","price_per_share":5.15,"price_display":"5.15","price_state":"stated","total_value":10063.1,"total_display":"10,063.10","total_whole":"10,063","shares_owned_after":166066.0,"shares_owned_after_display":"166,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-10","filed_date":"2018-08-10","scope":"insider"},{"id":6586176,"accession":"0001209191-18-046294","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-046294","line_url":"/filing/0001209191-18-046294#line-1","is_derivative":false,"issuer_cik":"0001509190","issuer_name":"ARATANA THERAPEUTICS, INC.","issuer_ticker":"PETX","issuer_name_source":null,"issuer_url":"/issuer/0001509190","owner_cik":"0001578908","owner_name":"HEINEN ERNST","owner_display_name":"HEINEN ERNST","owner_url":"/insider/0001578908","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2674.0,"shares_display":"2,674","price_per_share":5.15,"price_display":"5.15","price_state":"stated","total_value":13771.1,"total_display":"13,771.10","total_whole":"13,771","shares_owned_after":168020.0,"shares_owned_after_display":"168,020","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-08","filed_date":"2018-08-10","scope":"insider"},{"id":4991760,"accession":"0001209191-17-053353","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-053353","line_url":"/filing/0001209191-17-053353#line-1","is_derivative":false,"issuer_cik":"0001509190","issuer_name":"ARATANA THERAPEUTICS, INC.","issuer_ticker":"PETX","issuer_name_source":null,"issuer_url":"/issuer/0001509190","owner_cik":"0001578908","owner_name":"HEINEN ERNST","owner_display_name":"HEINEN ERNST","owner_url":"/insider/0001578908","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":6.25,"price_display":"6.25","price_state":"stated","total_value":62500.0,"total_display":"62,500.00","total_whole":"62,500","shares_owned_after":130994.0,"shares_owned_after_display":"130,994","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-09-15","filed_date":"2017-09-19","scope":"insider"},{"id":3258179,"accession":"0001209191-16-144606","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-144606","line_url":"/filing/0001209191-16-144606#line-1","is_derivative":false,"issuer_cik":"0001509190","issuer_name":"ARATANA THERAPEUTICS, INC.","issuer_ticker":"PETX","issuer_name_source":null,"issuer_url":"/issuer/0001509190","owner_cik":"0001578908","owner_name":"HEINEN ERNST","owner_display_name":"HEINEN ERNST","owner_url":"/insider/0001578908","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":10.0006,"price_display":"10.00","price_state":"stated","total_value":100006.0,"total_display":"100,006.00","total_whole":"100,006","shares_owned_after":115494.0,"shares_owned_after_display":"115,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-03","filed_date":"2016-10-04","scope":"insider"},{"id":2249739,"accession":"0001209191-16-127460","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-127460","line_url":"/filing/0001209191-16-127460#line-1","is_derivative":false,"issuer_cik":"0001509190","issuer_name":"ARATANA THERAPEUTICS, INC.","issuer_ticker":"PETX","issuer_name_source":null,"issuer_url":"/issuer/0001509190","owner_cik":"0001578908","owner_name":"HEINEN ERNST","owner_display_name":"HEINEN ERNST","owner_url":"/insider/0001578908","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":6.7241,"price_display":"6.72","price_state":"stated","total_value":100861.5,"total_display":"100,861.50","total_whole":"100,862","shares_owned_after":125494.0,"shares_owned_after_display":"125,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-10","filed_date":"2016-06-13","scope":"insider"},{"id":8827353,"accession":"0001209191-15-061546","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-061546","line_url":"/filing/0001209191-15-061546#line-1","is_derivative":false,"issuer_cik":"0001509190","issuer_name":"ARATANA THERAPEUTICS, INC.","issuer_ticker":"PETX","issuer_name_source":null,"issuer_url":"/issuer/0001509190","owner_cik":"0001578908","owner_name":"HEINEN ERNST","owner_display_name":"HEINEN ERNST","owner_url":"/insider/0001578908","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":17.0554,"price_display":"17.06","price_state":"stated","total_value":255831.0,"total_display":"255,831.00","total_whole":"255,831","shares_owned_after":97494.0,"shares_owned_after_display":"97,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-15","filed_date":"2015-07-17","scope":"insider"},{"id":6781699,"accession":"0001181431-14-017934","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-017934","line_url":"/filing/0001181431-14-017934#line-1","is_derivative":false,"issuer_cik":"0001509190","issuer_name":"ARATANA THERAPEUTICS, INC.","issuer_ticker":"PETX","issuer_name_source":null,"issuer_url":"/issuer/0001509190","owner_cik":"0001578908","owner_name":"HEINEN ERNST","owner_display_name":"HEINEN ERNST","owner_url":"/insider/0001578908","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":13.42,"price_display":"13.42","price_state":"stated","total_value":134200.0,"total_display":"134,200.00","total_whole":"134,200","shares_owned_after":95294.0,"shares_owned_after_display":"95,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-05","filed_date":"2014-05-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001509190","name":"ARATANA THERAPEUTICS, INC.","url":"/issuer/0001509190","role":"Officer (Chief Development Officer)","n_filings":9,"first_seen":"2014-05-05","last_seen":"2018-11-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001578908","retrieved_at":"2026-08-22T11:10:22+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}